Anemia in dialysis patients needs to be treated with supplemental erythropoietin or drugs such as roxarestat, and blood transfusion if necessary.
Dialysis is a form of life-sustaining treatment for uremic patients, who are often combined with renal anemia, mainly due to the inability of the kidneys to secrete enough erythropoietin, and some of the patients may suffer from gastrointestinal discomfort and eat less, which leads to insufficient intake of hematopoietic raw materials and exacerbates the anemia.
Therefore, the main treatment for anemia in dialysis patients is supplementation of exogenous erythropoietin or application of drugs such as roxarestat. Patients with hematopoietic material deficiencies also require additional supplementation with iron, folic acid, vitamin B12, and other hematopoietic materials.
If the anemia is so severe that it reaches the emergency blood transfusion indication, blood transfusion treatment is also needed.
Dialysis patients with anemia are advised to contact their dialysis centers and follow the doctor’s instructions for standardized treatment. The above medications should be used in accordance with the doctor’s prescription, and should not be used without authorization, so as not to aggravate the condition.